{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0011528/OMIM:605258","label":"Immunodeficiency with hyper-igm, type 2","mondoId":"MONDO:0011528","onsetQualifier":null,"recordKeys":["085703a750bc5f447cd2dc4cb2cc6f18756317fdd3eb5eff1357ae9d87bbbc82","20d53a5475fd99faf3684589877297c7d9d8a51884c0d797a4bed6ff3147fe4a","35ba705af810ea32d6167db6b15322d7f3e2f432b40e035300de3f823c6f3810","440ce19fbca702c4bbd4654aa076ebddf634dea9af2f06ce1d57aa840be1bcd0","45b4ec6aa079cb20fcad8259b03ffe664f55ce06fd7d7e5951a131a07f93141c","4d53d60a01b550f53c720deeb5b375d5bee720d940b4e33dc16935dbda630e56","5312c9b6fb61cab26e395f4445746f8992d91158f2b1d3c77da802fb573b920d","896da5d1f755d427f27f8ed3493b315abc24469818a5a9694e7754730de6a11f","89be20254286630cd69b6481e4fa0e0ba6b542a33ff7b7d050afac7879115c86","9d21e975832c825138ee97a8ff8b3e64def318c09d8e607b48d21f5cdb2240c6","fb81cbba543bdacc87fd1405c1cef15311cff24cb98be08ca356a0ce3b3faf72"],"recordQualifiers":{},"scopeLabel":"OMIM:605258","sourceIds":["OMIM:605258"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0011528/OMIM:605258"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":7,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":11,"sourceGroups":{"omim":0,"orphanet":0,"published":11}},"features":[{"hpoId":"HP:0410295","label":"Complete or near-complete absence of specific antibody response to tetanus vaccine","primary":false},{"hpoId":"HP:0002720","label":"Decreased circulating IgA concentration","primary":false},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":false},{"hpoId":"HP:0002721","label":"Immunodeficiency","primary":false},{"hpoId":"HP:0002959","label":"Impaired Ig class switch recombination","primary":false},{"hpoId":"HP:0003496","label":"Increased circulating IgM concentration","primary":false},{"hpoId":"HP:0002716","label":"Lymphadenopathy","primary":false},{"hpoId":"HP:0002718","label":"Recurrent bacterial infections","primary":false},{"hpoId":"HP:0004798","label":"Recurrent infection of the gastrointestinal tract","primary":false},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":false},{"hpoId":"HP:0200117","label":"Recurrent upper and lower respiratory tract infections","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0011528","records":[{"frequencyKind":"reported","key":"085703a750bc5f447cd2dc4cb2cc6f18756317fdd3eb5eff1357ae9d87bbbc82","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0200117","is_excluded":false,"label":"Recurrent upper and lower respiratory tract infections","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"20d53a5475fd99faf3684589877297c7d9d8a51884c0d797a4bed6ff3147fe4a","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"18/18","hpo_id":"HP:0002718","is_excluded":false,"label":"Recurrent bacterial infections","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"35ba705af810ea32d6167db6b15322d7f3e2f432b40e035300de3f823c6f3810","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"18/18","hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"440ce19fbca702c4bbd4654aa076ebddf634dea9af2f06ce1d57aa840be1bcd0","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0410295","is_excluded":false,"label":"Complete or near-complete absence of specific antibody response to tetanus vaccine","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"45b4ec6aa079cb20fcad8259b03ffe664f55ce06fd7d7e5951a131a07f93141c","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"18/18","hpo_id":"HP:0002720","is_excluded":false,"label":"Decreased circulating IgA concentration","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4d53d60a01b550f53c720deeb5b375d5bee720d940b4e33dc16935dbda630e56","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"18/18","hpo_id":"HP:0004798","is_excluded":false,"label":"Recurrent infection of the gastrointestinal tract","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"5312c9b6fb61cab26e395f4445746f8992d91158f2b1d3c77da802fb573b920d","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002959","is_excluded":false,"label":"Impaired Ig class switch recombination","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"896da5d1f755d427f27f8ed3493b315abc24469818a5a9694e7754730de6a11f","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"13/18","hpo_id":"HP:0002716","is_excluded":false,"label":"Lymphadenopathy","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"89be20254286630cd69b6481e4fa0e0ba6b542a33ff7b7d050afac7879115c86","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002721","is_excluded":false,"label":"Immunodeficiency","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9d21e975832c825138ee97a8ff8b3e64def318c09d8e607b48d21f5cdb2240c6","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"18/18","hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fb81cbba543bdacc87fd1405c1cef15311cff24cb98be08ca356a0ce3b3faf72","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:605258","disease_name":"Immunodeficiency with hyper-igm, type 2","evidence":"PCS","frequency_raw":"15/18","hpo_id":"HP:0003496","is_excluded":false,"label":"Increased circulating IgM concentration","onset_id":null,"reference":"PMID:11007475","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"hyper-igm-syndrome-type-2","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"hyper-IgM syndrome type 2"},"schemaVersion":1}